PMA supplement
P800036 S029: INFUSAID IMPLANTABLE INFUSION PUMP MODEL 400
FDA PMA supplement · Normal 180 Day Track · Intera Oncology
Key facts
| Original PMA | P800036 |
|---|---|
| Supplement number | S029 |
| Supplement type | Normal 180 Day Track |
| Reason for the supplement | Change Design/Components/Specifications/Material |
| Trade name | INFUSAID IMPLANTABLE INFUSION PUMP MODEL 400 |
| Generic name | Pump, infusion, implanted, programmable |
| Applicant | Intera Oncology |
| Product code | LKK |
| Received date | May 18, 1992 |
| Decision date | Jun 17, 1993 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: